Overall, these studies suggest that patients with T2DM may benefit from apelin administration by improving insulin sensitivity, increasing cardiac output (through direct heart stimulation) and enhancing blood flow (through blood vessel dilatation). The gene discussed is APLN; the disease is type 2 diabetes mellitus.